OpenURL Connection Search

Select item for more details and to access through your institution.

Pharmacokinetics and pharmacodynamics of SB 209670, an endothelin receptor antagonist: Effects on the regulation of renal vascular tone*.
Published in:
Clinical Pharmacology & Therapeutics, 1999, v. 65, n. 5, p. 473, doi. 10.1016/S0009-9236(99)70066-4
By:
- Freed, Martin I.;
- Wilson, Douglas E.;
- Thompson, Kathleen A.;
- Harris, Robert Z.;
- Ilson, Bernard E.;
- Jorkasky, Diane K.
Publication type:
Article
A dose-response study to assess the renal hemodynamic, vascular, and hormonal effects of eprosartan, an angiotensin II AT1-receptor antagonist, in sodium-replete healthy men*.
Published in:
Clinical Pharmacology & Therapeutics, 1998, v. 63, n. 4, p. 471, doi. 10.1016/S0009-9236(98)90043-1
By:
- Ilson, Bernard E.;
- Boike, Steven C.;
- Martin, David E.;
- Freed, Martin I.;
- Zariffa, Névine;
- Jorkasky, Diane K.
Publication type:
Article
Pharmacokinetics of famciclovir in subjects with varying degrees of renal impairment.
Published in:
Clinical Pharmacology & Therapeutics, 1994, v. 55, n. 4, p. 418, doi. 10.1038/clpt.1994.51
By:
- Boike, Steven C;
- Pue, Martin A;
- Freed, Martin I;
- Audet, Patricia R;
- Fairless, Amanda;
- Ilson, Bernard E;
- Zariffa, Névine;
- Jorkasky, Diane K
Publication type:
Article
Rosiglitazone, But Not Glyburide, Reduces Circulating Proinsulin and the Proinsulin: Insulin Ratio in Type 2 Diabetes.
Published in:
Journal of Clinical Endocrinology & Metabolism, 2004, v. 89, n. 12, p. 6048, doi. 10.1210/jc.2004-0705
By:
- SMITH, STEPHEN A.;
- PORTER, LISA E.;
- BISWAS, NANDITA;
- FREED, MARTIN I.
Publication type:
Article
Rosiglitazone Monotherapy Is Effective in Patients with Type 2 Diabetes.
Published in:
Journal of Clinical Endocrinology & Metabolism, 2001, v. 86, n. 1, p. 280, doi. 10.1210/jcem.86.1.7157
By:
- LEBOVITZ, HAROLD E.;
- DOLE, JO F.;
- PATWARDHAN, RITA;
- RAPPAPORT, ELIZABETH B.;
- FREED, MARTIN I.
Publication type:
Article
Improving Metabolic Control Leads to Better Working Memory in Adults With Type 2 Diabetes.
Published in:
Diabetes Care, 2006, v. 29, n. 2, p. 345, doi. 10.2337/diacare.29.02.06.dc05-1626
By:
- Ryan, Christopher M.;
- Freed, Martin I.;
- Rood, Julie A.;
- Cobitz, Alexander R.;
- Waterhouse, Brian R.;
- Strachan, Mark W. J.
Publication type:
Article
A diabetes outcome progression trial (ADOPT): an international multicenter study of the comparative efficacy of rosiglitazone, glyburide, and metformin in recently diagnosed type 2 diabetes.
Published in:
2002
By:
- Viberti, Giancarlo;
- Kahn, Steven E;
- Greene, Douglas A;
- Herman, William H;
- Zinman, Bernard;
- Holman, Rury R;
- Haffner, Steven M;
- Levy, Daniel;
- Lachin, John M;
- Berry, Rhona A;
- Heise, Mark A;
- Jones, Nigel P;
- Freed, Martin I
Publication type:
journal article
A Diabetes Outcome Progression Trial (ADOPT).
Published in:
Diabetes Care, 2002, v. 25, n. 10, p. 1737, doi. 10.2337/diacare.25.10.1737
By:
- Viberti, Giancarlo;
- Kahn, Steven E.;
- Greene, Douglas A.;
- Herman, William H.;
- Zinman, Bernard;
- Holman, Rury R.;
- Haffner, Steven M.;
- Levy, Daniel;
- Lachin, John M.;
- Berry, Rhona A.;
- Heise, Mark A.;
- Jones, Nigel P.;
- Freed, Martin I.
Publication type:
Article
Evaluation of liver function in type 2 diabetic patients during clinical trials: evidence that rosiglitazone does not cause hepatic dysfunction.
Published in:
2002
By:
- Lebovitz, Harold E.;
- Kreider, Margaret;
- Freed, Martin I.
Publication type:
journal article
A randomized trial of rosiglitazone therapy in patients with inadequately controlled insulin-treated type 2 diabetes.
Published in:
2001
By:
- Raskin, Philip;
- Rendell, Marc;
- Riddle, Matthew C.;
- Dole, Jo F.;
- Freed, Martin I.;
- Rosenstock, Julio;
- Raskin, P;
- Rendell, M;
- Riddle, M C;
- Dole, J F;
- Freed, M I;
- Rosenstock, J;
- Rosiglitazone Clinical Trials Study Group
Publication type:
journal article
Preclinical and clinical assessment of inhaled levodopa for OFF episodes in Parkinson’s disease.
Published in:
Science Translational Medicine, 2016, v. 8, n. 360, p. 1, doi. 10.1126/scitranslmed.aad8858
By:
- Lipp, Michael M.;
- Batycky, Richard;
- Moore, Jerome;
- Leinonen, Mika;
- Freed, Martin I.
Publication type:
Article
The effect of acarbose on the pharmacokinetics of rosiglitazone.
Published in:
European Journal of Clinical Pharmacology, 2001, v. 57, n. 2, p. 105, doi. 10.1007/s002280100275
By:
- Miller, Ann K.;
- Inglis, Anne;
- Culkin, Kathleen Thompson;
- Jorkasky, Diane K.;
- Freed, Martin I.
Publication type:
Article
Pharmacokinetics of Rosiglitazone in Patients with Varying Degrees of Renal Insufficiency.
Published in:
Journal of Clinical Pharmacology, 2003, v. 43, n. 3, p. 252, doi. 10.1177/0091270002250602
By:
- Chapelsky, Martha C.;
- Thompson-Culkin, Kathleen;
- Miller, Ann K.;
- Sack, Marshall;
- Blum, Robert;
- Freed, Martin I.
Publication type:
Article
Lack of Effect of Rosiglitazone on the Pharmacokinetics of Oral Contraceptives in Healthy Female Volunteers.
Published in:
Journal of Clinical Pharmacology, 2001, v. 41, n. 6, p. 683, doi. 10.1177/009127000104100612
By:
- Inglis, Anne Marie L.;
- Miller, Ann K.;
- Culkin, Kathleen Thompson;
- Finnerty, Dana;
- Patterson, Scott D.;
- Jorkasky, Diane K.;
- Freed, Martin I.
Publication type:
Article
Rosiglitazone Does Not Affect the Steady-State Pharmacokinetics of Digoxin.
Published in:
Journal of Clinical Pharmacology, 2000, v. 40, n. 12, p. 1516, doi. 10.1177/009127000004001225
By:
- Di Cicco, Robert A.;
- Miller, Ann K.;
- Patterson, Scott;
- Freed, Martin I.
Publication type:
Article
Rosiglitazone Does Not Alter the Pharmacokinetics of Metformin.
Published in:
Journal of Clinical Pharmacology, 2000, v. 40, n. 11, p. 1280, doi. 10.1177/009127000004001113
By:
- Di Cicco, Robert A.;
- Allen, Ann;
- Carr, Alison;
- Fowles, Susan;
- Jorkasky, Diane K.;
- Freed, Martin I.
Publication type:
Article
Rosiglitazone Has No Clinically Significant Effect on Nifedipine Pharmacokinetics.
Published in:
Journal of Clinical Pharmacology, 1999, v. 39, n. 11, p. 1189, doi. 10.1177/009127009903901112
By:
- Harris, Robert Z.;
- Inglis, Anne Marie L.;
- Miller, Ann K.;
- Thompson, Kathleen A.;
- Finnerty, Dana;
- Patterson, Scott;
- Jorkasky, Diane K.;
- Freed, Martin I.
Publication type:
Article
Eprosartan, an Angiotensin II Receptor Antagonist, Does Not Affect the Pharmacodynamics of Glyburide in Patients with Type II Diabetes Mellitus.
Published in:
1997
By:
- Martin, David E.;
- DeCherney, G. Stephen;
- Ilson, Bernard E.;
- Jones, Beverly A.;
- Boike, Steven C.;
- Freed, Martin I.;
- Jorkasky, Diane K.
Publication type:
Other
Pharmacokinetics of Famciclovir in Subjects with Chronic Hepatic Disease.
Published in:
1994
By:
- Boike, Steven C.;
- Pue, Martin;
- Audet, Patricia R.;
- Freed, Martin I.;
- Fairless, Amanda;
- Ilson, Bernard E.;
- Zariffa, Névine;
- Jorkasky, Diane K.
Publication type:
Other
Comparative Effects of Nabumetone, Sulindac, and Indomethacin on Urinary Prostaglandin Excretion and Platelet Function in Volunteers.
Published in:
1994
By:
- Freed, Martin I.;
- Audet, Patricia R.;
- Zariffa, Nevine;
- Krishna, G. Gopal;
- Ilson, Bernard E.;
- Everitt, Daniel E.;
- Brown, Linda E.;
- Rizzo, Susan M.;
- Nichols, Alice I.;
- Jorkasky, Diane K.
Publication type:
Other
Obesity Is a Major Determinant of the Association of C-Reactive Protein Levels and the Metabolic Syndrome in Type 2 Diabetes.
Published in:
Diabetes, 2006, v. 55, n. 8, p. 2357, doi. 10.2337/db06-0116
By:
- Kahn, Steven E.;
- Zinman, Bernard;
- Haffner, Steven M.;
- O'Neill, M. Colleen;
- Kravitz, Barbara G.;
- Yu, Dahong;
- Freed, Martin I.;
- Herman, William H.;
- Holman, Rury R.;
- Jones, Nigel P.;
- Lachin, John M.;
- Viberti, Giancarlo C.
Publication type:
Article
Phenotypic characteristics of GAD antibody-positive recently diagnosed patients with type 2 diabetes in North America and Europe.
Published in:
2004
By:
- Zinman, Bernard;
- Kahn, Steven E.;
- Haffner, Steven M.;
- O'Neill, M. Colleen;
- Heise, Mark A.;
- Freed, Martin I.;
- ADOPT Study Group
Publication type:
journal article
A randomized trial of inhaled levodopa (CVT-301) for motor fluctuations in Parkinson's disease.
Published in:
2016
By:
- LeWitt, Peter A.;
- Hauser, Robert A.;
- Grosset, Donald G.;
- Stocchi, Fabrizio;
- Saint‐Hilaire, Marie‐Helene;
- Ellenbogen, Aaron;
- Leinonen, Mika;
- Hampson, Neil B.;
- DeFeo‐Fraulini, Tia;
- Freed, Martin I.;
- Kieburtz, Karl D.
Publication type:
journal article
Exacerbation of radiocontrast nephrotoxicity by endothelin receptor antagonism.
Published in:
2000
By:
- Wang, Andrew;
- Holcslaw, Terry;
- Bashore, Thomas M.;
- Freed, Martin I.;
- Miller, Diane;
- Rudnick, Michael R.;
- Szerlip, Harold;
- Thames, Marc D.;
- Davidson, Charles J.;
- Shusterman, Neil;
- Schwab, Steven J.;
- Wang, A;
- Holcslaw, T;
- Bashore, T M;
- Freed, M I;
- Miller, D;
- Rudnick, M R;
- Szerlip, H;
- Thames, M D;
- Davidson, C J
Publication type:
journal article

Found: 24

Pharmacokinetics and pharmacodynamics of SB 209670, an endothelin receptor antagonist: Effects on the regulation of renal vascular tone<sup>*</sup>.

A dose-response study to assess the renal hemodynamic, vascular, and hormonal effects of eprosartan, an angiotensin II AT<sub>1</sub>-receptor antagonist, in sodium-replete healthy men<sup>*</sup>.

Pharmacokinetics of famciclovir in subjects with varying degrees of renal impairment.

Rosiglitazone, But Not Glyburide, Reduces Circulating Proinsulin and the Proinsulin: Insulin Ratio in Type 2 Diabetes.

Rosiglitazone Monotherapy Is Effective in Patients with Type 2 Diabetes.

Improving Metabolic Control Leads to Better Working Memory in Adults With Type 2 Diabetes.

A diabetes outcome progression trial (ADOPT): an international multicenter study of the comparative efficacy of rosiglitazone, glyburide, and metformin in recently diagnosed type 2 diabetes.

A Diabetes Outcome Progression Trial (ADOPT).

Evaluation of liver function in type 2 diabetic patients during clinical trials: evidence that rosiglitazone does not cause hepatic dysfunction.

A randomized trial of rosiglitazone therapy in patients with inadequately controlled insulin-treated type 2 diabetes.

Preclinical and clinical assessment of inhaled levodopa for OFF episodes in Parkinson’s disease.

The effect of acarbose on the pharmacokinetics of rosiglitazone.

Pharmacokinetics of Rosiglitazone in Patients with Varying Degrees of Renal Insufficiency.

Lack of Effect of Rosiglitazone on the Pharmacokinetics of Oral Contraceptives in Healthy Female Volunteers.

Rosiglitazone Does Not Affect the Steady-State Pharmacokinetics of Digoxin.

Rosiglitazone Does Not Alter the Pharmacokinetics of Metformin.

Rosiglitazone Has No Clinically Significant Effect on Nifedipine Pharmacokinetics.

Eprosartan, an Angiotensin II Receptor Antagonist, Does Not Affect the Pharmacodynamics of Glyburide in Patients with Type II Diabetes Mellitus.

Pharmacokinetics of Famciclovir in Subjects with Chronic Hepatic Disease.

Comparative Effects of Nabumetone, Sulindac, and Indomethacin on Urinary Prostaglandin Excretion and Platelet Function in Volunteers.

Obesity Is a Major Determinant of the Association of C-Reactive Protein Levels and the Metabolic Syndrome in Type 2 Diabetes.

Phenotypic characteristics of GAD antibody-positive recently diagnosed patients with type 2 diabetes in North America and Europe.

A randomized trial of inhaled levodopa (CVT-301) for motor fluctuations in Parkinson's disease.

Exacerbation of radiocontrast nephrotoxicity by endothelin receptor antagonism.